@entity1459 . What is the likelihood of further XXXX ?

@entity1 @entity66 @entity117 @entity1459 @entity453 @entity299 @entity583 @entity204 @entity1002
Wide variation in severity of @entity1459 requires an individualized approach. The goals are to stabilize the @entity1 's condition and prevent progression to @entity583 or @entity204 . The following points summarize the current status of diagnosis and treatment: @entity1 suspected of having @entity1459 but thought to be at low risk can be discharged after clinical evaluation if further outpatient evaluation within 72 hours is scheduled. @entity1 thought to be at intermediate or high risk should be hospitalized. Thrombolytic therapy should not be administered without evidence of @entity583 . Assessment of prognosis by noninvasive testing often aids in selection of appropriate therapy. Coronary angiography is appropriate in @entity1 judged to be at high risk for @entity299 on the basis of their clinical course or results of non-invasive testing. Coronary artery bypass grafting should be recommended in almost all @entity1 with @entity453 and many with @entity66 , especially those with @entity1002 . Percutaneous transluminal coronary angioplasty is also effective in selected @entity1 . The discharge care plan should include continued monitoring of symptoms, appropriate drug therapy (including @entity117 ), and risk-factor modification.
